PFBT
BEAM icon

Parkside Financial Bank & Trust’s Beam Therapeutics BEAM Stock Holding History

Parkside Financial Bank & Trust’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$596 Hold
25
– – ﹤0.01% 2522
2025
Q4 		$693 Buy
+25
New +$638 ﹤0.01% 2474
2025
Q3 		– Sell
-30
Closed -$511 – 2723
2025
Q2 		$511 Buy
30
+10
+50% +$174 ﹤0.01% 2536
2025
Q1 		$391 Buy
+20
New +$524 ﹤0.01% 2549

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Parkside Financial Bank & Trust's BEAM Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Beam Therapeutics (BEAM) position steady in Q1 2026 at 25 shares worth $596. The position accounts for ﹤0.01% of the portfolio, ranked #2522.

Parkside Financial Bank & Trust first reported a position in BEAM in Q1 2025 and has held it in 4 quarters since. The position peaked at $693 in Q4 2025. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Parkside Financial Bank & Trust held 25 shares of Beam Therapeutics worth $596 as of Q1 2026.
  • Parkside Financial Bank & Trust left its Beam Therapeutics share count unchanged in Q1 2026.
  • Beam Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2522 holding.
  • Parkside Financial Bank & Trust first reported a position in Beam Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • Parkside Financial Bank & Trust's Beam Therapeutics position peaked at $693 in Q4 2025.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.